Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients

References

• Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993; 18:998–1005.
   PubMed Web of Science ®Google Scholar
• Alvarez F, Berg PA, Bianchi FB, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zumBüschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31:929–938.
   PubMed Web of Science ®Google Scholar
• Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008; 48:169–176.
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology. 2008; 48:1540–1548.
   PubMed Web of Science ®Google Scholar
• Choi G, Peters MG. The challenge of diagnosing autoimmune hepatitis: Less is more. Hepatology. 2008; 48:10–12.
   Google Scholar
• Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, Heneghan MA. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology. 2009; 50:538–545.
   PubMedGoogle Scholar
• Muratori P, Granito A, Pappas G, Muratori L. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. Hepatology. 2009; 49:1782–1783.
   PubMed Web of Science ®Google Scholar
• Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, Tu C, Guo J, Zhang S, Wang J, Lu Y, Han Y, Shen L, Chen X, Hu X, Wang X, Chen C, Fu Q, Ma X. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol. 2011; 54:340–347.
   PubMed Web of Science ®Google Scholar
• Wiegard C, Schramm C, Lohse AW. Scoring systems for the diagnosis of autoimmune hepatitis: Past, present, and future. Semin Liver Dis. 2009; 29:254–261.
   Google Scholar
• Czaja AJ. Special clinical challenges in autoimmune hepatitis: The elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients. Semin Liver Dis. 2009; 29:315–330.
   PubMed Web of Science ®Google Scholar
• Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology. 2007; 46:1828–1835.
   PubMedGoogle Scholar
• Beland K, Lapierre P, Alvarez F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol. 2009; 15:1025–1034.
   PubMed Web of Science ®Google Scholar
• Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 1991; 13:701–706.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Doherty DG, Donaldson PT. Genetic bases of autoimmune hepatitis. Dig Dis Sci. 2002; 47:2139–2150.
   PubMed Web of Science ®Google Scholar
• Feld JJ, Heathcote EJ. Epidemiology of autoimmune liver disease. J Gastroenterol Hepatol. 2003; 18:1118–1128.
   PubMed Web of Science ®Google Scholar
• Montano-Loza AJ, Carpenter HA, Czaja AJ. Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis. Liver Int. 2006; 26:1201–1208.
   PubMedGoogle Scholar
• Vazquez-García MN, Alaez C, Olivo A, Debaz H, Pérez-Luque E, Burguete A, Cano S, de la Rosa G, Bautista N, Hernández A, Bandera J, Torres LF, Kershenobich D, Alvarez F, Gorodezky C. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol. 1998; 28:985–990.
   PubMed Web of Science ®Google Scholar
• Bittencourt P, Goldberg A, Cancado E, Porta G, Carrilho F, Farias A, Palacios S, Ciarella J, Abrantes C, Baggio V, Laudanna A, Kalil J. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol. 1999; 94:1907–1913.
   Google Scholar
• Czaja AJ, Souto EO, Bittencourt PL, Cancado EL, Porta G, Goldberg AC, Donaldson PT. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol. 2002; 37:302–308.
   PubMed Web of Science ®Google Scholar
• Fortes M, Machado I, Gil G, Fernández M, Dagher L, León R, Bianco N, Tassinari P. Genetic contribution of major histocompatibility complex class II region to type1autoimmune hepatitis susceptibility in Venezuela. Liver Int. 2007; 27:1409–1416.
   PubMedGoogle Scholar
• Pando M, Larriba J, Fernandez G, Fainboim H, Ciocca M, Ramonet M, Badia I, Daruich J, Findor J, Tanno H, Cañero C, Fainboim L. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: Evidence for differential genetic predisposition. Hepatology. 1999; 30:137–180.
   Google Scholar
• Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology. 1984; 4:622–627.
   PubMed Web of Science ®Google Scholar
• Brunt EM, Ramrakhiani S, Cordes BG, Neuschwander-Tetri BA, Janney CG, Bacon BR, di Bisceglie AM. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol. 2003; 16:49–56.
   Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, . Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41:1313–1321.
   PubMed Web of Science ®Google Scholar
• Heathcote E. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000; 31:1005–1013.
   PubMed Web of Science ®Google Scholar
• Chazouilleres O, Wenhdum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology. 1998; 28:296–301.
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol. 1999; 30:394–401.
   PubMed Web of Science ®Google Scholar
• Mehendiratta V, Mitroo P, Bombonati A, Navarro VJ, Rossi S, Rubin R, Herrine SK. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol. 2009; 7:98–103.
   PubMed Web of Science ®Google Scholar
• Lim KN, Casanova RL, Boyer TD, Bruno CJ. Autoimmune hepatitis in African Americans: Presenting features and response to therapy. Am J Gastroenterol. 2001; 96:3390–3394.
   PubMed Web of Science ®Google Scholar
• Zolfino T, Heneghan MA, Norris S, Harrison PM, Portmann BC, McFarlane IG. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut. 2002; 50:713–717.
   PubMed Web of Science ®Google Scholar
• Flores YN, Yee HFJr, Leng M, Escarce JJ, Bastani R, Salmerón J, Morales LS. Risk factors for chronic liver disease in Blacks. Mexican Americans, and Whites in the United States: Results from NHANES IV, 1999–2004. Am J Gastroenterol. 2008; 103:2231–2238.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev. 2000; 174:250–259.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Carpenter HA, Moore SB, Clinical LA. phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4. Liver Int. 2006; 26:552–558.
   PubMedGoogle Scholar
• Torre A. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1?. Ann Hepatol. 2011; 10:28–32.
   Google Scholar
• Zepeda-Gomez S, Montaño-Loza A, Zapata-Colindres JC, Paz F, Olivera-Martinez M, López-Reyes A, Granados J, Vargas-Alarcón G. HLA-DR allele frequencies in Mexican mestizos with autoimmune liver diseases including overlap syndromes. Immunol Invest. 2009; 38:276–283.
   PubMed Web of Science ®Google Scholar
• Gorodezky C, Alaez C, Vázquez-García MN, de la Rosa G, Infante E, Balladares S, Toribio R, Pérez-Luque E, Muñoz L. The genetic structure of Mexican Mestizos of different locations: Tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol. 2001; 62:979–991.
   PubMed Web of Science ®Google Scholar
• Lindor RA, Lindor KD. The value of observational research in liver diseases. Hepatology. 2011; 53:1–3.
   PubMed Web of Science ®Google Scholar